Hexokinase 2 mRNA (HK2 mRNA) (HK2 mRNA)

Hexokinase 2 (HK2) mRNA is the messenger RNA transcript that encodes the Hexokinase 2 enzyme, a pivotal protein in cellular energy metabolism. This enzyme catalyzes the phosphorylation of glucose to glucose-6-phosphate, which is the first and rate-limiting step of the glycolytic pathway. In many malignant tumors, HK2 mRNA is significantly overexpressed, driving the Warburg effect where cancer cells utilize aerobic glycolysis to support rapid growth and survival (Source: PubMed, PMID: 23503300). Targeting the mRNA directly through technologies such as small interfering RNA (siRNA) or antisense oligonucleotides (ASOs) allows for the specific knockdown of HK2 protein levels (Source: NCBI, Gene ID: 3099). This metabolic intervention aims to starve cancer cells of energy and biosynthetic precursors, thereby inducing apoptosis and sensitizing tumors to other treatments (Source: PubMed, PMID: 25100373). Unlike other hexokinase isoforms, HK2 expression in adults is largely restricted to insulin-sensitive tissues like skeletal muscle and adipose tissue, which may provide a therapeutic window for cancer treatment. However, the use of HK2 mRNA as a target faces challenges, including the need for efficient systemic delivery systems and the risk of disrupting normal glucose homeostasis (Source: UniProt, P52789). Current research is focused on optimizing RNA-based delivery platforms to enhance the precision of HK2 silencing in the tumor microenvironment.

Other names

HKII mRNAHexokinase type II mRNAHK2 transcript

Inhibition of protein translation or induction of mRNA degradation via RNA interference or antisense mechanisms, leading to decreased glycolytic flux.